Dezhi Sui

Sialic acid conjugate-modified liposomes enable tumor homing of epirubicin via neutrophil/monocyte infiltration for tumor therapy

Junqiang Ding, Dezhi Sui, Mingqi Liu et al. · Acta Biomaterialia · 2021 · 57 citations

Cell-based Drug Delivery, Tumor Biology, Tumor Therapy +9

Simultaneous dendritic cells targeting and effective endosomal escape enhance sialic acid-modified mRNA vaccine efficacy and reduce side effects

Xueying Tang, Jiashuo Zhang, Dezhi Sui et al. · Journal of Controlled Release · 2023 · 49 citations

Vaccination, Simultaneous Dendritic Cells, Cross-protection +9

Targeted delivery of zoledronic acid through the sialic acid - Siglec axis for killing and reversal of M2 phenotypic tumor-associated macrophages – A promising cancer immunotherapy

Xueying Tang, Dezhi Sui, Mingqi Liu et al. · International Journal of Pharmaceutics · 2020 · 37 citations

Zoledronic Acid, Drug Targeting, Siglec Axis +9

Sequential administration of sialic acid-modified liposomes as carriers for epirubicin and zoledronate elicit stronger antitumor effects with reduced toxicity

Dezhi Sui, Xueying Tang, Junqiang Ding et al. · International Journal of Pharmaceutics · 2021 · 26 citations

Lipid Preparation, Nanomedicine, Medicinal Chemistry +10

Cleavable-Branched Polymer-Modified Liposomes Reduce Accelerated Blood Clearance and Enhance Photothermal Therapy

Dezhi Sui, Yujie Wang, Wenliang Sun et al. · ACS Applied Materials & Interfaces · 2023 · 20 citations

Cell-based Drug Delivery, Nanomedicine, Ethylene Glycol +15